Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Camlin Fine Sciences Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹4,658.37Undervalued by 4,467.03%vs CMP ₹102.00

P/E (822.0) × ROE (15.0%) × BV (₹46.30) × DY (2.00%)

Defaults: ROE=15%

₹1,105.71Undervalued by 984.03%vs CMP ₹102.00
MoS: +90.8% (Strong)Confidence: 31/100 (Low)Models: 2 Under, 1 Fair, 2 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹3,099.3834%Under (+2938.6%)
Net Asset ValueAssets₹46.5320%Over (-54.4%)
EV/EBITDAEnterprise₹113.3417%Under (+11.1%)
ROCE CapitalReturns₹96.6314%Fair (-5.3%)
Revenue MultipleRevenue₹87.1515%Over (-14.6%)
Consensus (5 models)₹1,105.71100%Undervalued
Key Drivers: EPS CAGR -33.5% drags value — could be higher if earnings stabilize. | P/E of 822 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -33.5% · Defaults: ROE=15%

*Investments are subject to market risks

Analyst Summary

Camlin Fine Sciences Ltd operates in the Chemicals - Speciality - Others segment, NSE: CAMLINFINE | BSE: 532834, current market price is ₹102.00, market cap is 1,951 Cr.. At a glance, stock P/E is 822, ROE is 15.0 %, ROCE is 11.0 %, book value is 46.3, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹1,105.71, which is about 984.0% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹1,667 Cr versus the prior period change of 14.6%, while latest net profit is about ₹-158 Cr with a prior-period change of -50.5%. The 52-week range shown on this page is 335/96.2, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisCamlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN)…

This summary is generated from the stock page data available for Camlin Fine Sciences Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

54
Camlin Fine Sciences Ltd scores 54/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health59/100 · Moderate
ROCE 11.0% AverageROE 15.0% GoodD/E 0.99 ModerateInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money60/100 · Moderate
FII holding up 0.65% (6mo) Slight increaseDII holding up 3.94% MF buyingPromoter decreased by 1.05% Caution
Earnings Quality60/100 · Moderate
OPM stable around 13% SteadyWorking capital: 35 days (improving) Efficient
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +12% YoY GrowingOPM: 7.0% (down 5.0% YoY) Margin pressure
Industry Rank35/100 · Weak
P/E 822.0 vs industry 64.9 Premium to peersROCE 11.0% vs industry 13.0% Average3Y sales CAGR: 6% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:44 am

Market Cap 1,951 Cr.
Current Price 102
Intrinsic Value₹1,105.71
High / Low 335/96.2
Stock P/E822
Book Value 46.3
Dividend Yield0.00 %
ROCE11.0 %
ROE15.0 %
Face Value 1.00
PEG Ratio-24.56

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Camlin Fine Sciences Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Camlin Fine Sciences Ltd 1,951 Cr. 102 335/96.2822 46.30.00 %11.0 %15.0 % 1.00
Thirumalai Chemicals Ltd 2,171 Cr. 180 329/158 1270.00 %0.26 %4.13 % 1.00
Rossari Biotech Ltd 2,239 Cr. 404 768/37316.3 2260.12 %15.8 %12.2 % 2.00
Panama Petrochem Ltd 1,547 Cr. 256 411/2298.33 2221.96 %20.4 %15.9 % 2.00
Fineotex Chemical Ltd 2,428 Cr. 20.8 35.8/19.025.0 6.720.38 %23.8 %18.4 % 1.00
Industry Average12,530.04 Cr712.4964.87182.870.55%12.98%25.40%6.41

All Competitor Stocks of Camlin Fine Sciences Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 483388427420406386377381417431437424460
Expenses 428338383381381363345352366375378405427
Operating Profit 55504439252331295256591933
OPM % 11%13%10%9%6%6%8%8%12%13%14%4%7%
Other Income 310-8622-96-15-151-8-173-4
Interest 18121010201416232634161619
Depreciation 14161819192113151714181719
Profit before tax 2632816-12-10-94-23-142-08-11-9
Tax % 61%28%59%25%72%47%-13%48%-18%2,164%99%-0%65%
Net Profit 1023312-21-14-82-35-116-70-11-15
EPS in Rs 0.741.360.520.83-1.03-0.63-4.11-1.81-5.33-0.22-0.04-0.53-0.76

Last Updated: January 2, 2026, 4:03 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 4:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5095584895347218921,0491,1871,4121,6821,4541,6671,778
Expenses 4464743975027058199141,0001,2541,4711,2841,4471,645
Operating Profit 638492321673135187158211170220133
OPM % 12%15%19%6%2%8%13%16%11%13%12%13%8%
Other Income 99-11412143533-4-142-203-42
Interest 252424313241484241647011169
Depreciation 12161722272933445663566471
Profit before tax 355350-6-3117581059480-99-158-49
Tax % 18%-4%28%-26%-22%82%49%38%36%50%6%0%
Net Profit 295536-4-24330656040-105-158-63
EPS in Rs 2.715.113.30-0.96-2.180.042.233.563.452.96-4.94-7.40-3.22
Dividend Payout % 12%8%12%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)89.66%-34.55%-111.11%-500.00%112.50%900.00%116.67%-7.69%-33.33%-362.50%-50.48%
Change in YoY Net Profit Growth (%)0.00%-124.20%-76.57%-388.89%612.50%787.50%-783.33%-124.36%-25.64%-329.17%312.02%

Camlin Fine Sciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:10%
3 Years:6%
TTM:11%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:223%
Stock Price CAGR
10 Years:10%
5 Years:20%
3 Years:19%
1 Year:103%
Return on Equity
10 Years:-1%
5 Years:-2%
3 Years:-7%
Last Year:-15%

Last Updated: September 5, 2025, 1:30 am

Balance Sheet

Last Updated: December 10, 2025, 2:30 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 9101010121212131616171919
Reserves 84125167202359359391631732804848883871
Borrowings 150160180331373461539550646801683681672
Other Liabilities 126131123126273255290282396425424454476
Total Liabilities 3694264796691,0161,0871,2321,4751,7902,0451,9722,0372,037
Fixed Assets 83106140201278272306584601858816704700
CWIP 22325814591792421543461015
Investments 1111911511777886169
Other Assets 2623163134426097457408619661,1361,1021,2621,253
Total Assets 3694264796691,0161,0871,2321,4751,7902,0451,9722,0372,037

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 274672-9-15-9861171455113927
Cash from Investing Activity + -32-26-66-70-149-2-90-133-249-125-66-75
Cash from Financing Activity + -6-15-7911822633913660-8672
Net Cash Flow -124-1131815-12332-14-1324
Free Cash Flow -7195-39-34-78-4834-68-9379-16
CFO/OP 58%68%91%5%-33%10%77%82%111%34%110%30%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-87.00-76.00-88.00-299.00-357.00-388.00-404.00-363.00-488.00-590.00-513.00-461.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 7374569910486888377667272
Inventory Days 145184311277207219204200178255256233
Days Payable 13214417111015412711999112129154162
Cash Conversion Cycle 85114196266157178173184143192174143
Working Capital Days -4121-61943225540425135
ROCE %28%28%24%5%0%7%11%13%10%10%8%11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 17.64%16.52%48.03%48.03%48.04%48.03%48.03%48.03%49.09%49.09%49.08%48.03%
FIIs 10.18%10.11%1.61%0.99%1.69%1.01%0.81%0.76%1.47%2.88%2.11%2.12%
DIIs 12.32%9.31%3.89%3.75%4.55%4.88%4.23%3.38%3.83%4.14%5.48%7.77%
Government 0.03%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 59.82%64.01%46.46%47.22%45.73%46.07%46.93%47.83%45.61%43.88%43.33%42.07%
No. of Shareholders 52,92152,27857,09862,09858,16562,68767,75061,89358,11159,53857,66152,357

Shareholding Pattern Chart

No. of Shareholders

Camlin Fine Sciences Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Commodities Fund 4,624,431 1.89 67.182,957,1882025-12-15 01:00:0556.38%
Franklin India Opportunities Fund 3,135,785 0.55 45.552,764,1662025-12-15 01:00:0513.44%
ICICI Prudential Multicap Fund 2,665,909 0.24 38.731,802,3092025-12-15 01:00:0547.92%
Franklin India Multi Cap Fund 1,581,171 0.47 22.97N/AN/AN/A
JM Small Cap Fund 504,008 1.17 7.32N/AN/AN/A
ICICI Prudential Retirement Fund - Pure Equity 313,993 0.28 4.56N/AN/AN/A
ICICI Prudential MidCap Fund 82,527 0.02 1.2N/AN/AN/A
ICICI Prudential Business Cycle Fund 50,000 0 0.73N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) -8.03-5.583.454.654.13
Diluted EPS (Rs.) -7.95-5.503.414.563.68
Cash EPS (Rs.) -5.04-1.576.517.428.60
Book Value[Excl.RevalReserv]/Share (Rs.) 47.8148.2948.1843.2647.81
Book Value[Incl.RevalReserv]/Share (Rs.) 47.8150.9752.2548.5255.67
Revenue From Operations / Share (Rs.) 88.6896.32107.0489.9593.11
PBDIT / Share (Rs.) 11.845.3413.4411.8414.66
PBIT / Share (Rs.) 8.450.649.468.2711.19
PBT / Share (Rs.) 2.61-5.935.125.998.24
Net Profit / Share (Rs.) -8.44-6.262.533.855.13
NP After MI And SOA / Share (Rs.) -7.40-5.543.323.874.00
PBDIT Margin (%) 13.355.5412.5513.1615.74
PBIT Margin (%) 9.520.678.839.1912.01
PBT Margin (%) 2.94-6.154.776.668.85
Net Profit Margin (%) -9.51-6.502.364.285.50
NP After MI And SOA Margin (%) -8.34-5.753.094.294.29
Return on Networth / Equity (%) -15.47-11.356.929.169.43
Return on Capital Employeed (%) 13.470.8911.7210.7714.20
Return On Assets (%) -6.87-4.752.523.373.43
Long Term Debt / Equity (X) 0.290.400.540.580.50
Total Debt / Equity (X) 0.710.801.040.940.99
Asset Turnover Ratio (%) 0.830.800.460.480.52
Current Ratio (X) 1.401.371.371.501.66
Quick Ratio (X) 0.770.660.650.870.99
Inventory Turnover Ratio (X) 3.211.381.291.651.79
Interest Coverage Ratio (X) 2.231.483.615.204.98
Interest Coverage Ratio (Post Tax) (X) 1.590.081.852.692.74
Enterprise Value (Cr.) 3620.142050.952685.652687.502251.73
EV / Net Operating Revenue (X) 2.171.271.601.901.90
EV / EBITDA (X) 16.2722.9212.7214.4612.05
MarketCap / Net Operating Revenue (X) 1.890.921.191.551.50
Price / BV (X) 3.511.832.663.313.30
Price / Net Operating Revenue (X) 1.890.921.191.551.50
EarningsYield -0.04-0.060.020.020.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 886.49 Cr. and Equity Capital is Rs. 18.79 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersFloor 2 to 5, In GS Point, Mumbai Maharashtra 400098Contact not found
Management
NamePosition Held
Mr. Ashish DandekarChairman & Managing Director
Mr. Nirmal MomayaManaging Director
Mr. Arjun DukaneExecutive Director -Technical
Mr. Joseph Conrad D'souzaIndependent Director
Ms. Anagha DandekarNon Exe.Non Ind.Director
Mr. Harsha RaghavanNon Exe.Non Ind.Director
Mr. Jens Van NieuwenborghNon Exe.Non Ind.Director
Mr. Mahabaleshwar PalekarIndependent Director
Mr. Pradip KanakiaIndependent Director
Mr. Amol ShahIndependent Director
Ms. Radhika DudhatIndependent Director
Mr. Abeezar FaizullabhoyIndependent Director

FAQ

What is the intrinsic value of Camlin Fine Sciences Ltd and is it undervalued?

As of 23 April 2026, Camlin Fine Sciences Ltd's intrinsic value is ₹1105.71, which is 984.03% higher than the current market price of ₹102.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (15.0 %), book value (₹46.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd is trading at ₹102.00 as of 23 April 2026, with a FY2026-2027 high of ₹335 and low of ₹96.2. The stock is currently near its 52-week low. Market cap stands at ₹1,951 Cr..

How does Camlin Fine Sciences Ltd's P/E ratio compare to its industry?

Camlin Fine Sciences Ltd has a P/E ratio of 822, which is above the industry average of 64.87. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Camlin Fine Sciences Ltd financially healthy?

Key indicators for Camlin Fine Sciences Ltd: ROCE of 11.0 % is moderate. Dividend yield is 0.00 %.

Is Camlin Fine Sciences Ltd profitable and how is the profit trend?

Camlin Fine Sciences Ltd reported a net profit of ₹-158 Cr in Mar 2025 on revenue of ₹1,667 Cr. Compared to ₹60 Cr in Mar 2022, the net profit shows a declining trend.

Does Camlin Fine Sciences Ltd pay dividends?

Camlin Fine Sciences Ltd has a dividend yield of 0.00 % at the current price of ₹102.00. The company is currently not paying meaningful dividends.

Last Updated: April 2, 2026, 2:44 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532834 | NSE: CAMLINFINE
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Camlin Fine Sciences Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports